HOUSTON , May 7, 2014 /PRNewswire/ -- VAALCO Energy, Inc. (NYSE: EGY) today reported a net loss of $7.0 million or a loss of $0.12 per share for the first quarter of 2014 compared to net income $7.2 million or $0.12 per diluted share for the comparable period in 2013.
HOUSTON , April 30, 2014 /PRNewswire/ -- VAALCO Energy, Inc. (NYSE: EGY) today announced that it will hold a conference call to discuss its first quarter 2014 results on Thursday, May 8, 2014 , at 10:00 a.m. Central Time ( 11:00 a.m. Eastern Time ). Interested parties may participate by dialing 1 (800) 288-8961.
HOUSTON , April 23, 2014 /PRNewswire/ -- VAALCO Energy, Inc. (NYSE: EGY) today announced that Steve Guidry , VAALCO's Chief Executive Officer, will present at the 18th Annual Burkenroad Reports Investment Conference to be held at the Hyatt Regency Hotel in New Orleans on Friday, April 25, 2014 , at 9:30 a.m. Eastern Time ( 8:30 a.m. Central Time ).
Listeners can access the webcast at http://wsw.com/webcast/tulane13/egy .
VANCOUVER, British Columbia, May 13, 2014 (GLOBE NEWSWIRE) -- Valdor Technology International Inc. ("Valdor") (TSX-V:VTI) (OTC:VTIFF) is pleased to report first quarter cash receipts for the period ending March 31, 2014 totaled $316,930 (all amounts quoted in US Dollars). Cash received from first quarter sales was $169,475 and cash received from accounts receivables relating to Valdor's recent purchase of the business and assets of VideoWare, Inc., now called Niagara Streaming Media, was $147,455. Valdor acquired the Niagara Streaming Media business effective February 14, 2014.
LAVAL, Quebec , April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J.
LOS ANGELES , May 21, 2014 /PRNewswire/ -- Research Solutions, Inc. (OTC-PINK: RSSS) , a pioneer in facilitating the flow of information from the publishers of scientific, technical, and medical content to enterprise customers in Life Sciences and other research intensive organizations around the world, today announced that Valeant Pharmaceuticals had adopted Bibliogo, the literature management and collaboration web application add-on for the company's Article Galaxy software-as-a-service (SaaS) solution.
LAVAL, Quebec , May 21, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2014 annual meeting of shareholders today.
LAVAL, Quebec , April 23, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today its nominees to stand for election to the Board of Directors at its annual meeting of shareholders on May 20, 2014.
LAVAL, Quebec , May 12, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that certain of its subsidiaries have entered into settlement agreements with affiliates of Actavis plc related to Actavis' generic versions of Acanya® Gel, 1.2%/2.5%, and Tiazac ® XC.
LAVAL, Quebec , May 8, 2014 /PRNewswire/ -- 2014 First Quarter Total Revenue $1.9 billion ; an increase of 77% over the prior year Exceeded our expectations Launched 11 new products in the U.S. Positive organic growth in the U.S. despite the generic impact of Zovirax and RAM coupled with the new generic entry for Vanos Bausch + Lomb double-digit organic growth trend continued 2014 First Quarter GAAP EPS loss of $0.07 ; Cash EPS $1.76 , an increase of 35% over the prior year 2014 First Quarter GAAP Operating Cash Flow $484 million ; Adjusted Operating Cash Flow $636 million Adjusted operating cash flow represented over 100% of adjusted cash net income Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces first quarter financial results for 2014.
LAVAL, Quebec , April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, May 8, 2014 at 8:00 a.m. ET ( 5:00 a.m. PT ) to discuss results for the 2014 first quarter.
LAVAL, Quebec , May 23, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the Sanford C.
LAVAL, Quebec , May 1, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders.
NEW YORK (MarketWatch) -- Valeant Pharmaceuticals International Inc. (VRX) said it will host an investor meeting for Allergan (AGN) and Valeant shareholders on May 28 to discuss the previously announced plan to improve its bid for the botox maker.
By David Benoit
Activist investor William Ackman and Valeant Pharmaceuticals International Inc. revealed their offer to acquire the wrinkle treatment maker AllerganInc.
Valeant's offered to swap each Allergan (AGN) share for $48.30 in cash and 0.83 shares of Valeant common stock.
Valeura Announces Voting Results Canada NewsWire
CALGARY , May 15, 2014 /CNW/ - Valeura Energy Inc. (" Valeura " or the " Corporation ") (TSX: VLE) is pleased to provide the voting results from its annual
and special meeting of shareholders held on May 15, 2014 .
ROANOKE, Va., May 1, 2014 (GLOBE NEWSWIRE) -- Valley Financial Corporation (Nasdaq:VYFC) , parent holding company for Valley Bank, was ranked #102 on the list of the top performing community banks and thrifts in the nation by American Banker Magazine.
WAYNE, N.J. , May 20, 2014 /PRNewswire/ -- Valley National Bancorp (NYSE: VLY) ("Valley"), the holding company for Valley National Bank, announced today that a common stock cash dividend of $0.11 per share will be paid July 1, 2014 to shareholders of record on June 13 , 2014.
WAYNE, N.J. , May 23, 2014 /PRNewswire/ -- Valley National Bancorp (NYSE: VLY) ("Valley"), the holding company for Valley National Bank, announced that it will release its second quarter 2014 earnings before the market opens on Wednesday, July 30, 2014 .
Highlights: - Quarterly diluted earnings per-share were $2.08, or $2.20 before accounting for the fair value adjustment of Delta EMD shares on the Johannesburg Stock Exchange (see table on last page).
- The March 3, 2014 acquisition of DS-SM, a Danish manufacturer of engineered steel structures, contributed $17.3 million in sales and $1.9 million of operating income.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.